Cargando…

Nucleic Acid-Based Theranostics for Tackling Alzheimer's Disease

Nucleic acid-based technologies have received significant interest in recent years as novel theranostic strategies for various diseases. The approval by the United States Food and Drug Administration (FDA) of Nusinersen, an antisense oligonucleotide drug, for the treatment of spinal muscular dystrop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chakravarthy, Madhuri, Chen, Suxiang, Dodd, Peter R., Veedu, Rakesh N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667416/ https://www.ncbi.nlm.nih.gov/pubmed/29109789 http://dx.doi.org/10.7150/thno.21529

Ejemplares similares

In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies
por: Lipi, Farhana, et al.
Publicado: (2016)

Development of Novel Chemically-Modified Nucleic Acid Molecules for Efficient Inhibition of Human MAPT Gene Expression
por: Chakravarthy, Madhuri, et al.
Publicado: (2020)

Radiolabeling of Nucleic Acid Aptamers for Highly Sensitive Disease-Specific Molecular Imaging
por: Hassanzadeh, Leila, et al.
Publicado: (2018)

Aptamer-engineered (nano)materials for theranostic applications
por: Rabiee, Navid, et al.
Publicado: (2023)

Development of nucleic acid aptamer-based lateral flow assays: A robust platform for cost-effective point-of-care diagnosis
por: Wang, Tao, et al.
Publicado: (2021)

Systematic evaluation of 2′-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro
por: Chen, Suxiang, et al.
Publicado: (2019)

Author Correction: Systematic evaluation of 2′-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro
por: Chen, Suxiang, et al.
Publicado: (2020)

Synthesis of a Morpholino Nucleic Acid (MNA)-Uridine Phosphoramidite, and Exon Skipping Using MNA/2′-O-Methyl Mixmer Antisense Oligonucleotide
por: Chen, Suxiang, et al.
Publicado: (2016)

BACE1 Inhibition Using 2’-OMePS Steric Blocking Antisense Oligonucleotides
por: Chakravarthy, Madhuri, et al.
Publicado: (2019)

Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics
por: Yang, Dongbin, et al.
Publicado: (2020)

DNAzymes: Expanding the Potential of Nucleic Acid Therapeutics
por: Larcher, Leon M., et al.
Publicado: (2023)

An Update of Nucleic Acids Aptamers Theranostic Integration with CRISPR/Cas Technology
por: Roueinfar, Mina, et al.
Publicado: (2022)

Smart functional nucleic acid chimeras: Enabling tissue specific RNA targeting therapy
por: Aaldering, Lukas J, et al.
Publicado: (2015)

The Application of Nucleic Acid Amplification Strategies in Theranostics
por: Jiang, Yanxialei
Publicado: (2019)

Novel Chemically-modified DNAzyme targeting Integrin alpha-4 RNA transcript as a potential molecule to reduce inflammation in multiple sclerosis
por: Chakravarthy, Madhuri, et al.
Publicado: (2017)

Therapeutically Significant MicroRNAs in Primary and Metastatic Brain Malignancies
por: Balachandran, Akilandeswari A., et al.
Publicado: (2020)

Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures
por: Rahimizadeh, Kamal, et al.
Publicado: (2017)

G-rich VEGF aptamer with locked and unlocked nucleic acid modifications exhibits a unique G-quadruplex fold
por: Marušič, Maja, et al.
Publicado: (2013)

Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation
por: Raguraman, Prithi, et al.
Publicado: (2021)

Computational Investigation of Locked Nucleic Acid (LNA) Nucleotides in the Active Sites of DNA Polymerases by Molecular Docking Simulations
por: Poongavanam, Vasanthanathan, et al.
Publicado: (2014)

Unlocked nucleic acid modified primer-based enzymatic polymerization assay: towards allele-specific genotype detection of human platelet antigens
por: Le, Bao T., et al.
Publicado: (2018)

Enzymatic synthesis of DNA strands containing α-L-LNA (α-L-configured locked nucleic acid) thymine nucleotides
por: Højland, Torben, et al.
Publicado: (2012)

Editorial: Molecular and nanoscale engineering of nucleic acid theranostics and vaccines
por: Tan, Xiaohong, et al.
Publicado: (2023)

Alpha-l-Locked Nucleic Acid-Modified Antisense Oligonucleotides Induce Efficient Splice Modulation In Vitro
por: Raguraman, Prithi, et al.
Publicado: (2020)

A self-assembled, modular nucleic acid-based nanoscaffold for multivalent theranostic medicine
por: Andersen, Veronica Liv, et al.
Publicado: (2019)

Role of Exosomes in the Pathogenesis and Theranostic of Alzheimer’s Disease and Parkinson’s Disease
por: He, Aojie, et al.
Publicado: (2023)

Self-assembling asymmetric peptide-dendrimer micelles – a platform for effective and versatile in vitro nucleic acid delivery
por: Kokil, Ganesh R., et al.
Publicado: (2018)

Rational Design of Short Locked Nucleic Acid-Modified 2′-O-Methyl Antisense Oligonucleotides for Efficient Exon-Skipping In Vitro
por: Le, Bao T., et al.
Publicado: (2017)

Efficient Reverse Transcription Using Locked Nucleic Acid Nucleotides towards the Evolution of Nuclease Resistant RNA Aptamers
por: Crouzier, Lucile, et al.
Publicado: (2012)

Rapid One-Step Selection Method for Generating Nucleic Acid Aptamers: Development of a DNA Aptamer against α-Bungarotoxin
por: Lauridsen, Lasse H., et al.
Publicado: (2012)

Development of Theranostic Cationic Liposomes Designed for Image-Guided Delivery of Nucleic Acid
por: Do, Hai Doan, et al.
Publicado: (2020)

Treatment of Alzheimer's disease with framework nucleic acids
por: Shao, Xiaoru, et al.
Publicado: (2020)

Theranostic Nucleic Acid Binding Nanoprobe Exerts Anti-inflammatory and Cytoprotective Effects in Ischemic Injury
por: Chen, Howard H., et al.
Publicado: (2017)

Nucleic acid liquid biopsies in Alzheimer's disease: current state, challenges, and opportunities
por: Soelter, Tabea M., et al.
Publicado: (2022)

A Promising Approach: Magnetic Nanosystems for Alzheimer’s Disease Theranostics
por: Chaparro, Catarina I. P., et al.
Publicado: (2023)

A Peptide & Peptide Nucleic Acid Synthesis Technology for Transporter Molecules and Theranostics - The SPPS
por: Pipkorn, Ruediger, et al.
Publicado: (2014)

Nucleic Acid-Based Therapeutics for Pulmonary Diseases
por: Chen, Jing, et al.
Publicado: (2018)

Curcumin and Its Derivatives as Theranostic Agents in Alzheimer’s Disease: The Implication of Nanotechnology
por: Shabbir, Umair, et al.
Publicado: (2020)

Using gold nanobeacons as a theranostic technique to recognize, detect, and inhibit specific nucleic acids
por: Sousa, Diana Pacheco, et al.
Publicado: (2022)

Molecular Beacons of Xeno-Nucleic Acid for Detecting Nucleic Acid
por: Wang, Qi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tnfokktoaspu0o59cf5msd10ga